Key facts
- Dawn Health’s last known valuation is $59.8M (Dec 2021).
- It has raised $50.4M; the latest was Later Stage VC ($38.9M) in Feb 2026.
- Notable investors include Denmark's Export and Investment Fund, Cipio Partners, Chr. Augustinus Fabriker, Lars Marcher, Trifork — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Dawn Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Dawn Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dawn Health
Operator of an integrated software intended to develop digital health products that drive improved patient outcomes beyond the pill. The company's software specializes in the design, development, and creation of digital therapeutic products, and, in addition, offers strategic consulting and development services, enabling healthcare professionals to ensure partners can successfully launch, operate, and maintain their digital health products and therapies.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2016
- Employees
- 112
- Website
- dawnhealth.com/
- Ownership
- Privately Held (backing)
Dawn Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dawn Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dawn Health in its N-PORT filings yet. We sweep new filings monthly.